Structure Therapeutics In...

NASDAQ: GPCR · Real-Time Price · USD
19.61
1.08 (5.83%)
At close: Aug 15, 2025, 11:14 AM

Structure Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-122.53M -89.62M -51.32M -38.05K
Depreciation & Amortization
992K 295K 277K 72.00
Stock-Based Compensation
18.79M 8.19M 2.51M 1.49M
Other Working Capital
-343K 7.83M 815K 2.17K
Other Non-Cash Items
-16.86M -5.32M -558K 241.00
Deferred Income Tax
n/a n/a n/a 27.00
Change in Working Capital
2.96M 6.97M 2.97M 4.06K
Operating Cash Flow
-116.64M -79.49M -46.12M -32.16K
Capital Expenditures
-1.29M -2.17M -155K -1.21K
Cash Acquisitions
n/a n/a 61.95K -19.07K
Purchase of Investments
-702.52M -416.99M -123.45M -4.21K
Sales Maturities Of Investments
344.9M 151.05M 61.5M 23.28K
Other Investing Acitivies
n/a -231.38K -61.95K 19.07K
Investing Cash Flow
-358.91M -268.34M -62.11M 17.86K
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a -6K n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-1.8M -20.77M -2.48M -103.25M
Financial Cash Flow
515.26M 451.53M 29.01M 103.25K
Net Cash Flow
39.72M 103.7M -79.21M 88.95K
Free Cash Flow
-117.93M -81.66M -46.27M -33.37K